Evidence map›Paper›PMID 8289830›Full record

ArticleMolecular and cellular biology1994

Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein.

E Gulbins, K M Coggeshall, C Langlet, G Baier, N Bonnefoy-Berard, P Burn, A Wittinghofer, S Katzav, A Altman

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Vav regulates peptide-specific apoptosis in thymocytes.The Journal of experimental medicine · 1998
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. p95vav associates with the nuclear protein Ku-70.Molecular and cellular biology · 1996
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Binding of Vav to Grb2 through dimerization of Src homology 3 domains.Proceedings of the National Academy of Sciences of the United States of America · 1994
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

E GulbinsDivision of Cell Biology, La Jolla Institute for Allergy and Immunology, California 92037.
K M Coggeshall
C Langlet
G Baier
N Bonnefoy-Berard
P Burn
A Wittinghofer
S Katzav
A Altman
La Jolla Institute for Immunology · US

Funding

T CELLS AND THEIR LYMPHOKINES IN CANCER IMMUNOTHERAPYR01CA035299 · NCI · SCRIPPS RESEARCH INSTITUTE · PI ALTMAN, AMNON · 1985 to 2013
$3.8M
NCI NIH HHS CA35299
6 · The paper itself

Abstract

We recently identified Vav, the product of the vav proto-oncogene, as a guanine nucleotide exchange factor (GEF) for Ras. Vav is enzymatically activated by lymphocyte antigen receptor-coupled protein tyrosine kinases or independently by diglycerides. To further evaluate the physiological role of Vav, we assessed its GDP-GTP exchange activity against several Ras-related proteins in vitro and determined whether Vav activation in transfected NIH 3T3 fibroblasts correlates with the activity status of Ras and mitogen-activated protein (MAP) kinases. In vitro translated purified Vav activated by phorbol myristate acetate (PMA) or phosphorylation with recombinant p56lck displayed GEF activity against Ras but not against recombinant RacI, RacII, Ral, or RhoA proteins. Expression of vav or proto-vav in stably transfected NIH 3T3 cells led to a approximately 10-fold increase in basal or PMA-stimulated Ras exchange activity, respectively, in total-cell lysates and Vav immunoprecipitates. Elevated GEF activity was paralleled in each case by a significant increase in the proportion of active, GTP-bound Ras. PMA had a minimal effect on the low Ras. GTP level in untransfected control fibroblasts but increased it from 20 to 37% in proto-vav-transfected cells. vav-transfected cells displayed a constitutively elevated Ras. GTP level (35%), which was not increased further by PMA treatment. MAP kinases, known downstream intermediates in Ras-dependent signaling pathways, similarly exhibited increased basal or PMA-stimulated activity in Vav-expressing cells by comparison with normal NIH 3T3 cells. These results demonstrate a physiologic interaction between Vav and its target, Ras, leading to MAP kinase activation.

Indexed as

Cell Cycle Proteins3T3 CellsAnimalsCalcium-Calmodulin-Dependent Protein KinasesCell LineClone CellsFibroblastsGTP-Binding ProteinsGuanosine DiphosphateHumansKineticsMiceOncogenesProtein BiosynthesisProto-Oncogene MasProto-Oncogene ProteinsCalcium-Calmodulin-Dependent Protein KinasesCell Cycle ProteinsGTP-Binding ProteinsGuanosine DiphosphateHRAS protein, humanMAS1 protein, humanProto-Oncogene MasProto-Oncogene ProteinsProto-Oncogene Proteins c-vavProto-Oncogene Proteins p21(ras)Tetradecanoylphorbol AcetateVAV1 protein, humanVav1 protein, mouse

Identifiers

PMID8289830
PMCPMC358445
OpenAlexW1902647910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.